Chemoinformaics analysis of 8-hydroxyquinoline
| Molecular Weight | 145.161 | nRot | 0 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 11 |
| Exact Molecular Weight | 145.053 | nRing | 2 |
| Solubility: LogS | -2.25 | nHRing | 1 |
| Solubility: LogP | 1.9 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 21.5996 |
| nHD | 1 | BPOL | 8.16245 |
| QED | 0.614 |
| Synth | 1.756 |
| Natural Product Likeliness | -0.304 |
| NR-PPAR-gamma | 0.912 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.003 |
| HIA | 0.018 |
| CACO-2 | -4.483 |
| MDCK | 0.0000298 |
| BBB | 0.442 |
| PPB | 0.852332 |
| VDSS | 1.048 |
| FU | 0.137647 |
| CYP1A2-inh | 0.867 |
| CYP1A2-sub | 0.589 |
| CYP2c19-inh | 0.388 |
| CYP2c19-sub | 0.456 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.237 |
| CYP2d6-sub | 0.784 |
| CYP3a4-inh | 0.065 |
| CYP3a4-sub | 0.219 |
| CL | 10.778 |
| T12 | 0.785 |
| hERG | 0.016 |
| Ames | 0.468 |
| ROA | 0.484 |
| SkinSen | 0.802 |
| Carcinogencity | 0.289 |
| EI | 0.986 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.18 |
| Antiviral | No |
| Prediction | 0.759645 |